Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
Vishnu Priya Pulipati/LinkedIn
Mar 14, 2026, 19:28

Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction

Vishnu Priya Pulipati, Founder and Host of LipidCurious Podcast, Member of Institutional Review Ethics Board at Saint Francis Health System, shared on LinkedIn:

”Let’s talk about statins. I know… boring, right?

Most of us already know a lot about them.

But thinking of statins only as cholesterol drugs misses the bigger picture.

In many ways, statins are best understood as Anti-atherosclerotic therapies that modify plaque biology, vascular inflammation, and cardiovascular risk far beyond simple LDL reduction.

In this episode, we cover:

  • Pleiotropic effects of statins beyond LDL-C lowering
  • Choosing the right statin in special populations
  • Why statins remain foundational therapy even in the era of newer lipid-lowering drugs

Bonus: Visual guide to help you navigate the episode.

Free CME/CE available for listening.

Listen at www.lipidcurious.com, Apple Podcasts, Spotify, or YouTube Podcasts.

Want a companion resource? Download the free LipidCurious Starter Kit.

Questions or feedback? [email protected]

Disclaimer: Educational content only. Not medical advice.

Clinicians should use independent clinical judgment and applicable guidelines.”

Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction

Stay updated with Hemostasis Today.

Atherosclerosis Health Hematology Hemostasis Hemostasis News Hemostasis Today LDL LipidCurious Podcast Medicine statins thrombosis Vishnu Priya Pulipati
NewsFeed